Skip to content
Clinical Trials – home

A-Shine s.r.o.

Research siteFast reply

Czechia Sumavska 2, Vychodni Predmesti, 301 00 Plzen, Czechia

  • 19 trials recruiting
  • Major depression · Dementia Alzheimer's type · Schizophrenia
  • Adult patients

About Specializations

A-Shine s.r.o. in Plzen, Czechia specialises in clinical trials of conditions such as Major depression, Dementia Alzheimer's type, Schizophrenia, Generalised anxiety disorder, and other specialisations. This site conducts important research.

Main research areas of the site

Rheumatology

The medical center is at the forefront of rheumatology research, focusing on innovative treatments for rheumatoid arthritis. The ongoing studies aim to enhance the efficacy of new therapeutic agents, providing hope for improved patient outcomes.

  • Rheumatoid Arthritis

By exploring novel compounds, the center contributes significantly to the understanding and management of autoimmune disorders.

Psychiatry

Specializing in psychiatry, the center conducts pivotal research on schizophrenia and major depressive disorder. The focus is on adjunctive therapies that enhance the effectiveness of existing treatments, addressing the needs of patients with inadequate responses to standard care.

  • Schizophrenia
  • Major Depressive Disorder

These studies are crucial in developing comprehensive treatment plans that improve mental health outcomes.

Neurology

The center is a leader in neurology, particularly in the study of Alzheimer's disease and cognitive impairments. Research efforts are directed towards understanding the safety and efficacy of new drugs in managing mild cognitive impairment and dementia.

  • Alzheimer's Disease
  • Cognitive Disorders

Through these investigations, the center aims to advance therapeutic strategies that slow disease progression and enhance quality of life for patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Sumavska 2, Vychodni Predmesti301 00 PlzenCzechia
Recruiting now
19 trials
Conditions studied
13

More sites in PlzenCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

39 clinical trials

A study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer's disease

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Schizophrenia

Recruiting

Study of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Evenamide
  • Sponsor:Newron Pharmaceuticals S.p.A.

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Seltorexant
  • Sponsor:Janssen Cilag International

Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Neurocrine Biosciences Inc.

A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Brexanolone caprilcerbate
  • Sponsor:Seaport Therapeutics Inc.

A Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Brexanolone caprilcerbate
  • Sponsor:Seaport Therapeutics Inc.

Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer's disease

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
  • Sponsor:Neurocrine Biosciences Inc.

Study of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Deupsilocin besilate
  • Sponsor:Cybin IRL Limited

Long-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Deupsilocin besilate
  • Sponsor:Cybin IRL Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.